WallStreetZenWallStreetZen
Analyst Ranking
Top 12%
#507 out of 4233 analysts
Average Return
+10.19%
Win Rate
50%24 out of 48
Risk vs Reward
Poor
Good

Jessica Fye's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Stemline Therapeutics IncSTML
+178.35%$4.25$11.83
2020-03-25 -
2020-06-10
Strong Buy
Ascendis Pharma AASND
+134.77%$27.90$65.50
2017-05-10 -
2018-05-11
Strong Buy
Nektar TherapeuticsNKTR
+88.09%$4.87$0.58
2022-08-07 -
2023-05-31
Strong Sell
Tricida IncTCDAQ
+80.43%$0.55$0.11
2022-10-24 -
2023-01-23
Strong Sell
United Therapeutics CorpUTHR
+67.73%$97.67$163.82
2020-01-30 -
2021-01-29
Strong Buy

Jessica Fye's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alkermes PLCALKS
2Hold$31.00+7.16%Maintains
a month ago
Legend Biotech CorpLEGN
2Strong Buy$76.00+18.44%Maintains
a month ago
Moderna IncMRNA
4Hold$140.00+9.62%Maintains
2 months ago
Biontech SeBNTX
3Hold$128.00+21.81%Maintains
2 months ago
Cerevel Therapeutics Holdings IncCERE
2Hold$29.00-11.04%Downgrades
3 months ago
Novocure LtdNVCR
2Strong Sell$50.00-30.37%Downgrades
3 months ago
Emergent Biosolutions IncEBS
1Strong Sell$9.00+5.51%Downgrades
3 months ago
Intra Cellular Therapies IncITCI
2Strong Buy$58.00-2.32%Maintains
3 months ago
Esperion Therapeutics IncESPR
5Hold$9.00+561.76%Maintains
3 months ago
Halozyme Therapeutics IncHALO
3Strong Buy$52.00+60.35%Maintains
3 months ago
Seagen IncSGEN
2Strong Buy$150.00-23.35%Maintains
4 months ago
Incyte CorpINCY
2Hold$80.00+29.98%Maintains
4 months ago
United Therapeutics CorpUTHR
5Strong Buy$265.00+26.35%Maintains
7 months ago
Tricida IncTCDAQ
2Strong SellN/AN/ADowngrades
7 months ago
Vertex Pharmaceuticals IncVRTX
1Strong Buy$327.00+1.06%Maintains
7 months ago
Biomarin Pharmaceutical IncBMRN
1Strong Buy$112.00+28.82%Maintains
7 months ago
Alnylam Pharmaceuticals IncALNY
1Hold$200.00+8.10%Maintains
7 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$67.00+21.42%Maintains
9 months ago
Nektar TherapeuticsNKTR
2Strong SellN/AN/ADowngrades
10 months ago
Amarin Corp PLCAMRN
1Strong SellN/AN/ADowngrades
a year ago
Cara Therapeutics IncCARA
2Strong Buy$20.00N/AUpgrades
a year ago
Landos Biopharma IncLABP
2Hold$70.00N/AMaintains
a year ago
Insmed IncINSM
1Strong Buy$45.00N/AInitiates Coverage On
a year ago
Stoke Therapeutics IncSTOK
1Strong Buy$41.00N/AUpgrades
2 years ago
Mirum Pharmaceuticals IncMIRM
1Strong Buy$30.00N/AInitiates Coverage On
2 years ago
Magenta Therapeutics IncMGTA
1Hold$7.00N/ADowngrades
2 years ago
Axcella Health IncAXLA
1Strong SellN/AN/ADowngrades
2 years ago
Crinetics Pharmaceuticals IncCRNX
1Strong Buy$28.00N/AUpgrades
2 years ago
Lava Therapeutics NvLVTX
1Strong Buy$22.00N/AInitiates Coverage On
2 years ago
Aptinyx IncAPTX
1Strong SellN/AN/ADowngrades
2 years ago
Lexicon Pharmaceuticals IncLXRX
1Hold$7.00N/AUpgrades
2 years ago
Stemline Therapeutics IncSTML
2Strong Buy$8.00N/AMaintains
3 years ago
Arena Pharmaceuticals IncARNA
1Strong Buy$58.00N/AUpgrades
3 years ago
Aprea Therapeutics IncAPRE
1Hold$460.00N/AInitiates Coverage On
4 years ago
Mersana Therapeutics IncMRSN
4Strong SellN/AN/ADowngrades
4 years ago
Amag Pharmaceuticals IncAMAG
1Strong Sell$18.00N/ADowngrades
5 years ago
Radius Health IncRDUS
4Strong Buy$52.00N/AMaintains
5 years ago
Deciphera Pharmaceuticals IncDCPH
2Strong Buy$33.00N/AMaintains
5 years ago
Chimerix IncCMRX
1Strong SellN/AN/ADowngrades
5 years ago
Enanta Pharmaceuticals IncENTA
1HoldN/AN/ADowngrades
5 years ago
Denali Therapeutics IncDNLI
1Strong Buy$24.00N/AInitiates Coverage On
5 years ago
Advanced Accelerator Applications SaAAAP
1HoldN/AN/ADowngrades
6 years ago
Biocryst Pharmaceuticals IncBCRX
1Strong BuyN/AN/AUpgrades
6 years ago
Ascendis Pharma AASND
1Strong Buy$36.00N/AInitiates Coverage On
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.